Elucent Medical Inc.

Elucent Medical develops the EnVisio® System, a real-time 3D surgical guidance platform incorporating In-Body Spatial Intelligence™ technology. The system transforms standard surgical instruments into smart tools by attaching miniaturized spatial tracking components (SmartSensor™, SmartClip®, SmartSurface™) that provide continuous three-dimensional localization of target tissue during procedures. The EnVisio platform delivers 5x greater depth visualization compared to traditional localization methods, enabling surgeons to precisely locate and target lesions, tumors, and other anatomical targets with enhanced accuracy. The technology integrates seamlessly with existing surgical instruments and operating room workflows, minimizing tool transfer time and maintaining uninterrupted visibility throughout procedures. Key clinical applications include tumor localization, tissue resection guidance, and complex surgical navigation. The system has been adopted by major health systems including Prisma Health, UCLA Health, and Novant Hill. Elucent's platform emphasizes real-time spatial awareness, intuitive user interface, and compatibility with cardiac implants and other metallic devices. The company positions its technology as a modernization of surgical precision guidance, reducing the need for additional verification methods during procedures.